Call for Abstracts

Submit your AAIC Satellite Symposium abstract by August 16.

The Alzheimer's Association International Conference® (AAIC®) Satellite Symposium is September 25 - 27 in Sydney, Australia. Share your latest findings in a wide variety of topic areas, including:

  • Basic and translational science.

  • Diagnosis and prognosis.

  • Public health and psychosocial.

  • Therapeutics.

Submissions will be considered for a poster presentation, as well as a special opportunity to deliver a Lightning Session — a short presentation designed to give the audience a snapshot of your work. Each session is five minutes or less.

Abstracts are due August 16 at 11:59 p.m. ET.

Don't miss an update!

All abstract submission and notification process emails will be sent from Add this address to your safe sender list or address book to ensure you receive all communications.

The submitter will receive an email during step 1 of the submission process and when your submission is complete. Invitation emails are sent to the presenting author only. It is your responsibility to contact the Alzheimer's Association at if you do not receive the system-generated emails.

<< Information to know before you begin your submission >>

Navigation Tips:

  1. As you complete each step, click on the "Save" and/or "Next Step" button at the bottom of the screen.
  2. Navigate to previous steps via the "Abstract Control Panel" (left side of the screen).
  3. Avoid using your browser's back and forward buttons.

Abstract ID and Password

  • Submitters will receive an e-mail message as soon as Step 1 is completed. Retain the email for your records, as it contains your abstract ID, password and a direct web link. After submission is complete, all emails will be sent to the presenting author only.
  • How to resume, edit, or withdraw your submission: Use the web link sent in the submission email or enter you abstract ID in the box on the right side of this screen. You may edit through the submission deadline.
Important Dates

<< Important Dates >>

Date Event
Tuesday, May 14, 2019 Submission Site Opens
Friday, August 16, 2019 Submission Site Closes
Friday, August 23, 2019 Abstract notifications sent via email
Friday, August 30, 2019 Responses due from invited presenting authors
September 25 - 27, 2019 Alzheimer’s Association International Conference Satellite Symposium

Prepare for your submission(s)

<< What to prepare for your submission(s) >>

Poster Submission:

  1. Choose the Theme, Topic, and Subtopic
  2. Abstract Title (English Only)
  3. Abstract Description (English Only)
    The following headers are required:
    • Background
    • Methods
    • Results
    • Conclusions

    All four sections combined cannot exceed 350 words. Verify the word count prior to entry.

    References must be included in the abstract body. Files submitted during submission listing references will not appear in the published version of the abstract.

  4. Files for Tables and Figures cannot be uploaded in the body of the abstract but can be added as a separate file(s). Acceptable formats: .jpeg, .gif, or .png)
    1. If you plan to upload tables or figures to supplement your abstract, save them in advance as JPG, PNG, or GIF files.
    2. Save one figure, chart or table per file. Do not add multiple images to one file or they may not appear in the published version of the abstract.
    3. Up to 6 files may be uploaded.
    4. Word, Excel, and PDF files are not accepted.
    5. Text only files will be excluded from the published version of the abstract.
  5. Author Information (collect the information below in advance)
  • Full Name
  • E-mail Address
  • Institution/Organization
  • City, State/Province, Country, Zip/Postal Code
  • Phone Number

(if applicable; submitter is required to submit this information)

  • Full Name
  • Degree(s)
  • Institution/Organization
  • E-mail Address
  • City, State/Province, Country

Embargo Policy

<< Embargo Policy and Confidentiality Agreement >>

AAIC Embargo Policy

The Alzheimer's Association International Conference® (AAIC®) is a well-recognized, global platform for news regarding advances in Alzheimer's and dementia research. If you are interested in having the research you present at AAIC eligible for inclusion in AAIC news releases and news conferences, it must not be published (online or hard copy) or presented, in whole or in part, in any manner, previous to presentation at AAIC. (Note: The Association reserves the right to also include previously published material in its news program, if it so chooses, but this is generally not the case.)

All materials submitted to AAIC are embargoed for publication and broadcast until the officially scheduled date and time of presentation at AAIC, unless the Alzheimer's Association provides written notice of change of date and/or time in advance, such as on an AAIC news release. If there are questions, please contact the Alzheimer's Association Public Relations Department at

  • The news embargo for abstracts and scientific presentations included in the AAIC news program will be listed on the news release that includes that abstract/presentation. This is regardless of the actual time of presentation at AAIC.
  • News embargoes for plenaries and oral sessions not included in the AAIC news program are at the beginning of each individual talk (not the overall session). For example, for an oral presentation session starting at 2:00 pm where each talk is 15 minutes, the news embargo on the:
    • 1st talk = 2:00 pm
    • 2nd talk = 2:15 pm
    • 3rd talk = 2:30 pm
  • The news embargo on a poster session is at the scheduled beginning of the session.

Public and news announcements made in advance of AAIC that a scientist or company is scheduled to make a presentation at AAIC may include the date, time, location and topic of presentation, but may not include the methods, results and/or conclusions, nor the type or direction of results, even if that is included in the name/title of the submitted abstract. For that reason, authors are discouraged from putting the type and/or direction of results in the abstract title.

All news media representatives, scientists and their funders, and exhibitors/sponsors agree to honor the news embargoes and release times stated on news releases and other news materials issued by the Alzheimer's Association/AAIC.

If a reporter or news media outlet breaks an AAIC news embargo, the Alzheimer's Association reserves the right to revoke their press access and credentials for the current event and future Alzheimer's Association conferences and events.

If a scientist or company that is a participant in an AAIC news briefing or news release is discovered to have broken the news embargo, or encouraged the breaking of a news embargo, the Alzheimer's Association reserves the right to remove the participant from the news briefing and remove that scientist's/company's information from the news release. In addition, consequences for violation of the news embargo may include retraction of the accepted abstract from AAIC and/or loss of privileges of presenting research at AAIC in the future.

SEC-Related Issues

If a publicly traded company is advised that it is legally required to disclose certain data or other information from a confidential AAIC abstract in advance of the AAIC news embargo to satisfy requirements of the U.S. Securities and Exchange Commission or a corresponding regulatory body in a country where the company's stock is traded (collectively, "SEC"), that company must submit to AAIC, in advance of the SEC-required disclosure:

  • Written notification of the time, manner and recipients of the company's release; and
  • A letter signed by the company's legal counsel, advising that (a) public disclosure of the information is necessary for the company to comply with applicable securities laws, and (b) the information disclosed is the minimum necessary for such compliance.

If this is done, the abstract will not be automatically rejected or removed from AAIC on the basis of the SEC-required release of data or other information, though the situation is still subject to AAIC review. At a minimum, AAIC may in its discretion change the position of the abstract in AAIC, e.g., from oral presentation to poster. The abstract will most likely be ineligible for the AAIC news program.

The company may issue a news release at the time of SEC-required disclosure. The AAIC abstract itself may not be released publicly by the company or lead author. Mention may be made that full details will be presented at AAIC. AAIC would prefer that the news release:

  • Summarize study data cited in the abstract in a qualitative rather than quantitative manner.
  • Avoid interpretations about the implications of the data for practice.

As an example, a statement that a study "met its primary endpoint of improving cognition" is qualitative, while "ADAS-Cog scores remained stable for 18 months in the treated group" would be considered quantitative. A quote such as "We are encouraged by these promising results" would not be viewed as interpretive, while a quote such as "These findings support [drug] as first line therapy in mild to moderate Alzheimer's" would be seen as an interpretation of the data.

AAIC Confidentiality Agreement

Abstracts and related information submitted to the Alzheimer’s Association International Conference (AAIC®) meetings are considered final and confidential from the time of submission. This Confidentiality Agreement covers all abstracts, title of abstract and summary description placeholders ("Confidential Information"). Compliance with the Confidentiality Agreement is required by all parties receiving Confidential Information, which includes all embargoed or early copies of the abstracts shared with news media, as these documents are confidential per this policy and each recipient will be held accountable for any violations of AAIC’s Confidentiality Policy.

Prior to the Confidential Information being publicly released by the Alzheimer’s Association in conjunction with the AAIC, authors, coauthors, sponsors of the research, news media, journalists, analysts, other AAIC attendees, and recipients of Confidential Information may not:

  • Make the information public, or provide it to others who may make it public
  • Publish or present the information or provide it to others who may publish or present it
  • Use the information for any commercial purposes, pecuniary purposes, securities trading, securities recommendations and/or securities analysis until such information has been presented at AAIC and been reasonably absorbed on a broader basis into the market.

For a study to be eligible for acceptance into the AAIC, information contained in the abstract, as well as additional data and information to be presented about the study at AAIC, must not be disclosed before the findings have been publicly released in conjunction with AAIC.

Unless express permission is granted by the Alzheimer’s Association, which may be obtained directly upon request, the contents and conclusions of the abstract must not be presented at any scientific, medical or educational meeting or published in a scientific, medical or educational publication (in any medium) in whole or in part, before AAIC. If attendees wish to have information from an abstract or portions of the dataset disclosed in advance of public release in conjunction with AAIC, specific exception requests must be made per the Confidentiality Agreement Exception instructions described below.

Alzheimer’s Association recognizes that certain federal and international laws require disclosure of certain clinical trial results through federal and international registries within a certain time period. If the imposed deadline for data submission falls before AAIC meeting dates, submission of the trial results to the required registry will not be viewed as a breach of AAIC’s Confidentiality Agreement.

Confidentiality Agreement Exceptions

Exceptions to the AAIC Confidentiality Agreement require communication with Alzheimer’s Association a minimum of 48 hours in advance of any public release. Specific inquiries about exceptions to the AAIC Confidentiality Agreement should be emailed to

A Securities and Exchange Commission (“SEC”) Exception is available to companies whose securities are publicly traded to the extent that disclosure is necessary for that company to comply with the disclosure requirements under any US federal or state or international securities laws.

The obligations above shall not extend to any part of the Confidential Information (a) that can be demonstrated to have been in the public domain or publicly known at the time of disclosure; (b) that becomes part of the public domain or publicly known by publication or otherwise, not due to any unauthorized act by the abstract submitter; (c) that can be demonstrated as independently developed by the abstract submitter without reference to or reliance upon such Confidential Information; or (d) that is required to be disclosed by law, in which case the abstract submitter will notify the Alzheimer’s Association of such requirement.

Other Exceptions to the AAIC Confidentiality Agreement may be granted by the Alzheimer’s Association in specific circumstances including but not limited to public health reasons and/or to meet the requirements of state, national or international government agencies.

No matter if a Confidentiality Agreement Exception applies or is granted, Alzheimer’s Association retains the right, in its sole discretion, to change an abstract’s placement in the meeting program based on the extent of information disclosed. If an exception applies or is granted, the study will most likely be ineligible for the official AAIC news program.

If the confidentiality policy is broken, the Alzheimer’s Association retains the right, in its sole discretion, to: remove the abstract from AAIC, deny the responsible author(s) attendance at AAIC, and/or bar the responsible author(s) from future submission and/or attendance at AAIC.

News Embargo-Related FAQ's:

Is advance promotion of general topics, speakers, or presentation times permitted?

Public and news announcements made in advance of AAIC that a scientist or company is scheduled to make a presentation of AAIC may include the date, time, location and topic of presentation, but may not include the methods, results and/or the type or direction of results, even if that is included in the name/title of the submitted abstract. For that reason, authors are discouraged from putting the type and/or direction of results in the abstract title.

Is it acceptable to submit an abstract that presents partial data from a manuscript submitted for publication?

It is not acceptable to submit partial data from a manuscript already submitted for publication AND published in any form before the AAIC news embargo date/time. It is acceptable only if the author(s) and journal guarantee in writing to AAIC that any publication would not occur until after the AAIC news embargo date/time.

Will the submission of this abstract to affect the publication of our manuscript?

No. These review processes are independent. The thresholds for acceptance between conference abstracts and journal manuscripts are very different.

Frequently Asked Questions

<< Frequently Asked Questions >>

What do I need to prepare for my submission?

Click here to view a detailed list.

What are the themes and topics?

  • Basic and Translational Science
  • Diagnosis and Prognosis
  • Policy
  • Public Health and Psychsocial
  • Social Justice/Social Change
  • Therapeutics
  • Other
Do I need to be present in person and register?


What is the age requirement for presenting authors?

Presenting authors must be 18 years of age at the time of the conference (September 25-27 ).

What are the poster dimensions?

  • Landscape display
  • Inches: 91 in (wide) x 44.75 in (high)
  • Meters: 2.3114 m (wide) x 1.13665 m (high)
  • Push-pins and/or tape will be provided.
Am I allowed to submit abstracts that have been previously presented?

All abstracts submitted to AAIC must be made up substantially of new findings, data, or analyses.

How do I make edits to an abstract in "submitted" status?

You may make edits to your submitted proposal through the submission deadline. Access your in-progress or submitted proposal by logging in (top right corner of this screen). It is your responsibility to confirm that your abstract is correctly submitted and is received by the submission deadline. Send an email to if changes are required after the submission deadline (changes are approved on a case-by-case basis).

When will I be notified if my abstract has been accepted?

Notifications of acceptance/denial of abstract submissions will be sent by August 23, 2019.

Does the Alzheimer's Association own accepted abstracts?

Accepted abstracts become the property of the Alzheimer's Association. Ownership of submitted abstracts not accepted for presentation reverts to the author.

If my abstract is accepted, will it be used by the Association for sales or marketing purposes?

The Alzheimer's Association reserves the right to provide abstracts to conference registrants and the public via online modalities, a mobile application, and any other modalities they wish. In those formats, the abstracts become the property of the Association, along with the PowerPoint slides or handout material.

If I need to retract my abstract submission, what is the deadline?

You can retract your abstract submission at any time. Depending on our publication deadlines, we may be unable to remove your abstract from print materials and publications. To retract an accepted abstract, you must email and confirm a response.

If my abstract is accepted, how do I make an author change or withdraw my abstract?

If the identified presenting author becomes unable to present, a co-author may present. Notification of the change must be submitted in writing to If none of the authors on the abstracts can present, a request must be submitted in writing to to withdraw the abstract. Depending on deadlines, we may be unable to remove your abstracts from print materials and publications.

Questions & Technical Support

<< Questions & Technical Support >>

Topic Email Phone
General AAIC and abstract Questions +1.312.335.5897
Hours: 9am - 5pm Central Time, Monday-Friday
Technical Support (log in issues, technical entry issues) Tech Support 1.401.334.0220
Hours: 8:30am - 6pm Eastern Time, Monday-Friday
Please view all sections of this site prior to contacting the Association or Technical Support.

AAIC Main Website

Call for Abstracts Instructions

Forgotten ID and password?
We will email it to you.

Privacy Policy